Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis.
- 1 August 1993
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 88 (2) , 454-460
- https://doi.org/10.1161/01.cir.88.2.454
Abstract
BACKGROUND: Oral anticoagulation is most frequently monitored using the prothrombin time, but an alternative approach is measurement of native, fully carboxylated, prothrombin antigen (NPA). We have correlated results of the prothrombin time and NPA with development of venous thrombosis or bleeding complications in a clinical trial of warfarin prophylaxis following total hip arthroplasty to determine the potential value of NPA measurement for monitoring oral anticoagulation. METHODS AND RESULTS: Patients in one arm of a prospective, randomized trial received warfarin prophylactically beginning 10 to 14 days before total hip arthroplasty in a dose adjusted to prolong the international normalized ratio (INR) to 1.5 on the day of surgery and 2.5 after surgery. NPA was measured by ELISA, and the prothrombin time was measured using rabbit brain thromboplastin. Samples were tested from 97 patients, and data from 81 patients who had adequate venography were analyzed to correlate test results with occurrence of thrombosis. The prothrombin time and INR were less sensitive than NPA to the lowest intensities of anticoagulation, with the prothrombin time index increasing from 1.0 to 1.3 and the INR increasing from 1.0 to 2.0, whereas the NPA concentration decreased fourfold, from 200 to 50 micrograms/mL. There was little correlation between either the prothrombin time index or the INR and the development of thrombosis, whereas NPA concentrations were significantly higher on the day of surgery and on postoperative days 1, 3, 5, and 7 in patients who developed venous thrombosis. Higher concentrations of NPA were associated with an increased risk of venous thrombosis, but there was no relation between thrombosis and the prothrombin time index or INR. There was no significant correlation between surgical blood loss and prothrombin time index, INR, or NPA concentration. However, patients who received the largest number of transfusions on the day of surgery had significantly lower NPA concentrations than patients who required no transfusion. CONCLUSIONS: These results indicate that the NPA concentration more accurately reflects the antithrombotic effect of warfarin than does prothrombin time and may be superior in monitoring prophylactic oral anticoagulation.Keywords
This publication has 20 references indexed in Scilit:
- The molecular basis of blood coagulationCell, 1988
- Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacementThe Journal of Arthroplasty, 1987
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Venous thrombosis after elective hip replacement—the influence of preventive intermittent calf compression and of surgical techniqueBritish Journal of Surgery, 1983
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- Warfarin anticoagulation: Difficulties in interpretation of the prothrombin timeThrombosis Research, 1982
- Vitamin K-Dependent Formation of γ-Carboxyglutamic AcidAnnual Review of Biochemistry, 1977
- Assessment of Anticoagulant Treatment of Venous ThromboembolismAnnals of Surgery, 1969
- Survival Time of Prothrombin and Factors VII, IX and X after Completely Synthesis Blocking Doses of Coumarin DerivativesBritish Journal of Haematology, 1963
- Relation of Hemorrhage and Thrombosis to Prothrombin during Treatment with Coumarin-Type AnticoagulantsNew England Journal of Medicine, 1958